# Comparison of MECHANISM of Early and Late Vascular Responses Following Treatment of ST-elevation Acute Myocardial Infarction With Two Different Everolimus-eluting Stents: Randomized Controlled Trial Between Biodegradable Polymer and Durable Polymer Stent (MECHANISM-AMI-RCT)

Study · id `cardio:ct-nct03726892` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03726892](<https://clinicaltrials.gov/study/NCT03726892>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03726892

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 120 participants.

## Technical summary

Registry record NCT03726892. Randomized; single masking; primary purpose treatment. Start 2018-11-12 (actual); primary completion 2020-05-28 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT03726892, source copy `cardio:ctgov-nct03726892-2020-06-02`, retrieved 2026-10-26)
- Started: 2018-11-12 (actual) (ClinicalTrials.gov record NCT03726892, source copy `cardio:ctgov-nct03726892-2020-06-02`, retrieved 2026-10-26)
- Primary completion: 2020-05-28 (actual) (ClinicalTrials.gov record NCT03726892, source copy `cardio:ctgov-nct03726892-2020-06-02`, retrieved 2026-10-26)
- Completion: 2022-07-01 (anticipated) (ClinicalTrials.gov record NCT03726892, source copy `cardio:ctgov-nct03726892-2020-06-02`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT03726892, source copy `cardio:ctgov-nct03726892-2020-06-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03726892-2020-06-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of MECHANISM of Early and Late Vascular Responses Following Treatment of ST-elevation Acute Myocardial Infarction With Two Different Everolimus-eluting Stents: Randomized Controlled Trial Between Biodegradable Polymer and Durable Polymer Stent (MECHANISM-AMI-RCT)
- Condition: Coronary Artery Disease
- Intervention (Device): PCI
- Lead sponsor: Iwate Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 788a3cb4f64295cd17b4dc42a55e3017ef9530230db2d4f527c4f6119c3bb344
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
